المؤلفون: Isabella Bonilha, Andrei C. Sposito, Pedro Vellosa Schwartzmann, Elza Muscellie, Wilson Nadruz, B.M. Luchiari, Otávio Rizzi Coelho, Riobaldo M. R. Cintra, Luiz F. Carvalho, Otavio R. Coelho-Filho, Ana C. C. Nogueira

المصدر: The Journal of Clinical Endocrinology & Metabolism. 106:3060-3067

مصطلحات موضوعية: Male, Drug, medicine.medical_specialty, Diabetic Cardiomyopathies, Endocrinology, Diabetes and Metabolism, media_common.quotation_subject, Network Meta-Analysis, Clinical Biochemistry, 030204 cardiovascular system & hematology, Biochemistry, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Internal medicine, medicine, Humans, Hypoglycemic Agents, 030212 general & internal medicine, Sodium-Glucose Transporter 2 Inhibitors, Dipeptidyl peptidase-4, Proportional Hazards Models, Randomized Controlled Trials as Topic, media_common, Heart Failure, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Incidence, Biochemistry (medical), Hazard ratio, Type 2 Diabetes Mellitus, Middle Aged, medicine.disease, Metformin, Hospitalization, Treatment Outcome, Diabetes Mellitus, Type 2, Meta-analysis, Heart failure, Drug Therapy, Combination, Female, Thiazolidinediones, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b561b157db94f5c04e4fb57ffa990976
https://doi.org/10.1210/clinem/dgab428